Methods and kits to identify klebsiella strains
Embodiments of the invention provide a method of detecting one or more strains of Klebsiella pneumoniae . The method may include forming a plurality of mixtures for nucleic amplification. The method can include amplification of specific sequences within the K. pneumonia genome that can provide definitive information to distinguish between one or more types or strains of K. pneumonia.
1. A method of detecting carbapenem-resistant Enterobacteriaceae in a sample, the method comprising the steps of:
adding to a mixture comprising the sample a first oligonucleotide consisting of SEQ ID NO: 1, a second oligonucleotide consisting of SEQ ID NO: 2, and a third oligonucleotide consisting of SEQ ID NO: 3;
subjecting the mixture to conditions that allow nucleic acid amplification; and
detecting the carbapenem-resistant Enterobacteriaceae in the sample by detecting nucleic acid amplification in the mixture.
2. The method of claim 1 , wherein the nucleic acid amplification comprises calculating a Ct value.
3. The method of claim 1 , wherein the sample comprises an environmental sample.
4. The method of claim 1 , wherein the sample is derived from a subject, wherein the subject is human, an animal, an insect, a plant, or a bacteria.
5. The method of claim 4 , wherein the sample comprises sputum.
6. The method of claim 1 , wherein the carbapenem-resistant Enterobacteriaceae is Klebsiella pneumoniae.
7. A method of detecting a Klebsiella pneumoniae carbapenemase (KPC)-producing isolate in a sample, the method comprising the steps of:
adding to a first mixture comprising the sample a first oligonucleotide consisting of SEQ ID NO: 1, a second oligonucleotide consisting of SEQ ID NO: 2, and a third oligonucleotide consisting of SEQ ID NO: 3;
adding to a second mixture comprising the sample a fourth oligonucleotide consisting of SEQ ID NO: 1, a fifth oligonucleotide consisting of SEQ ID NO: 2, and a sixth oligonucleotide consisting of SEQ ID NO: 4;
subjecting the first mixture and second mixture to conditions that allow nucleic acid amplification; and
detecting the KPC-producing isolate in the sample by detecting the nucleic acid amplification in the first mixture and second mixture, wherein nucleic acid amplification in the first mixture indicates presence of the KPC-producing isolate.
8. The method of claim 7 , wherein nucleic acid amplification in the second mixture indicates absence of the KPC-producing isolate.
9. The method of claim 7 , wherein the KPC-producing isolate is ST258.
10. The method of claim 7 , wherein detecting the nucleic acid amplification comprises calculating a Ct value.
11. The method of claim 10 , wherein if the ST258 strain of the KPC-producing isolate is present in the sample, the Ct value in the first mixture will be lower than the Ct value in the second mixture.
12. The method of claim 7 , wherein the sample comprises an environmental sample.
13. The method of claim 7 , wherein the sample is derived from a subject, wherein the subject is a human, an animal, an insect, a plant, or a bacteria.
14. The method of claim 13 , wherein the sample comprises sputum.
15. A method of detecting a Klebsiella pneumoniae ST258 strain in a sample, the method comprising the steps of:
adding to a mixture comprising the sample a first oligonucleotide consisting of SEQ ID NO: 1, a second oligonucleotide consisting of SEQ ID NO: 2, a third oligonucleotide consisting of SEQ ID NO: 3, and a fourth oligonucleotide consisting of SEQ ID NO: 4;
subjecting the mixture to conditions that allow nucleic acid amplification; and
detecting the Klebsiella pneumoniae ST258 strain in the sample by detecting nucleic acid amplification of SEQ ID NO: 3 in the mixture.
16. The method of claim 15 , wherein the sample comprises an environmental sample.
17. The method of claim 15 , wherein the sample is from a subject, wherein the subject is human, an animal, an insect, a plant, or a bacteria.
18. The method of claim 17 , wherein if the Klebsiella pneumoniae ST258 strain is detected in the subject the method further comprises of the step of administering to the subject a therapeutically effective amount of an antibiotic to which the Klebsiella pneumoniae ST258 strain is sensitive.